Advertisement

Does a run/walk strategy decrease cardiac stress during a marathon in non-elite runners?

Published:November 13, 2014DOI:https://doi.org/10.1016/j.jsams.2014.11.010

      Abstract

      Objectives

      Although alternating run/walk-periods are often recommended to novice runners, it is unclear, if this particular pacing strategy reduces the cardiovascular stress during prolonged exercise. Therefore, the aim of the study was to compare the effects of two different running strategies on selected cardiac biomarkers as well as marathon performance.

      Design

      Randomized experimental trial in a repeated measure design.

      Methods

      Male (n = 22) and female subjects (n = 20) completed a marathon either with a run/walk strategy or running only. Immediately after crossing the finishing line cardiac biomarkers were assessed in blood taken from the cubital vein. Before (−7 days) and after the marathon (+4 days) subjects also completed an incremental treadmill test.

      Results

      Despite different pacing strategies, run/walk strategy and running only finished the marathon with similar times (04:14:25 ± 00:19:51 vs 04:07:40 ± 00:27:15 [hh:mm:ss]; p = 0.377). In both groups, prolonged exercise led to increased B-type natriuretic peptide, creatine kinase MB isoenzyme and myoglobin levels (p < 0.001), which returned to baseline 4 days after the marathon. Elevated cTnI concentrations were observable in only two subjects. B-type natriuretic peptide (r = −0.363; p = 0.041) and myoglobin levels (r = −0.456; p = 0.009) were inversely correlated with the velocity at the individual anaerobic threshold. Run/walk strategy compared to running only reported less muscle pain and fatigue (p = 0.006) after the running event.

      Conclusions

      In conclusion, the increase in cardiac biomarkers is a reversible, physiological response to strenuous exercise, indicating temporary stress on the myocyte and skeletal muscle. Although a combined run/walk strategy does not reduce the load on the cardiovascular system, it allows non-elite runners to achieve similar finish times with less (muscle) discomfort.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Science and Medicine in Sport
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gulati M.
        • Pandey D.K.
        • Arnsdorf M.F.
        • et al.
        Exercise capacity and the risk of death in women. The St. James Women Take Heart Project.
        Circulation. 2003; 108: 1554-1559
        • Maron B.J.
        • Poliac L.C.
        • Roberts W.O.
        Risk for sudden cardiac death associated with marathon running.
        JACC. 1996; 28: 428-431
        • Neilan T.G.
        • Januzzi J.L.
        • Lee-Lewandrowski T.T.
        • et al.
        Myocardial Injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon.
        Circulation. 2006; 114: 2325-2333
        • Karlstedt E.
        • Chelvanathan A.
        • Da Silva M.
        • et al.
        The impact of repeated marathon running on cardiovascular function in the aging population.
        J Cardiovasc Magn Reson. 2012; 14: 1-7
        • Lucia A.
        • Serratosa L.
        • Saborido A.
        • et al.
        Shortterm effects of marathon running: no evidence of cardiac dysfunction.
        Med Sci Sport Exerc. 1999; 31: 1414-1421
        • Aagaard P.
        • Sahlen A.
        • Braunschweig F.
        Performance trends and associations with biomarkers in a 30 km cross-country race.
        Med Sci Sport Exerc. 2011; 44: 849-894
        • Doust J.A.
        • Pietrzak E.
        • Dobson A.
        • et al.
        How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.
        BMJ. 2005; 330: 1-9
        • Lippi G.
        • Schena F.
        • Salvagno G.L.
        • et al.
        Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run.
        Scand J Clin Lab Invest. 2008; 68: 667-672
        • Wilson M.G.
        • O’Hanlon R.
        • Prasad S.
        • et al.
        Biological markers of cardiac damage are not related to measures of cardiac systolic and diastolic function using cardiovascular magnetic resonance (CMR) and echocardiography following an acute bout of prolonged endurance exercise.
        Br J Sports Med. 2011; 45: 780-784
        • Regwan S.
        • Hulten E.A.
        • Martinho S.
        • et al.
        Marathon running as a cause of troponin elevation: a systematic review and meta-analysis.
        J Interv Cardiol. 2010; 23: 443-450
        • Fortescue E.B.
        • Shin A.Y.
        • Greenes D.S.
        • et al.
        Cardiac troponin increases among runners in the Boston marathon.
        Ann Emerg Med. 2007; 49: 137-143
        • Loftin M.
        • Waddell D.E.
        • Robinson J.H.
        • et al.
        Comparison of energy expenditure to walk or run a mile in adult normal weight and overweight men and women.
        J Strength Cond Res. 2010; 24: 2794-2798
        • Galloway J.
        Half-marathon – You Can Do It.
        5th ed. Meyer & Meyer Sport, Maidenhead2013
        • Stanton M.M.
        • Petersen S.R.
        • Dressendorfer R.H.
        Intermittent walking fails to alter physiological responses to a paced 24 km run.
        Sports Med Train Rehab. 2000; 9: 225-237
        • Vuorimaa T.
        • Ahotupa M.
        • Häkkinen K.
        • et al.
        Different hormonal response to continuous and intermittent exercise in middle-distance and marathon runners.
        Scand J Med Sci Sports. 2008; 18: 565-572
        • Haney T.
        • Mercer J.
        A description of variability of pacing in marathon distance running.
        Int J Exerc Sci. 2011; 4: 133-140
        • Dickhuth H.-H.
        • Huonker M.
        • Münzel T.
        • et al.
        Individual anaerobic threshold for evaluation of competitive athletes and patients with left ventricular dysfunction.
        Advances in Ergometry. Springer Verlag, Berlin & Heidelberg1991: 170-173
        • Biewener A.A.
        • Farley C.T.
        • Roberts T.J.
        • et al.
        Muscle mechanical advantage of human walking and running: implications for energy cost.
        J Appl Physiol. 2004; 97: 2266-2274
        • Billat V.L.
        • Wesfreid E.
        • Kapfer C.
        • et al.
        Nonlinear dynamics of heart rate and oxygen uptake in exhaustive 10,000 m runs: influence of constant vs. freely paced.
        J Physiol Sci. 2006; 56: 103-111
        • Renfree A.
        • St Clair Gibson A.
        Influence of different performance levels on pacing strategy during the Women's World Championship marathon race.
        Int J Sports Physiol Perform. 2013; 8: 279-285
        • Siegel A.
        • Lewandrowski E.
        • Chun K.
        • et al.
        Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathon.
        Am J Cardiol. 2001; 88: 920-923
        • Smith J.E.
        • Garbutt G.
        • Lopes P.
        • et al.
        Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department.
        Br J Sports Med. 2004; 38: 292-294
        • Siegel A.
        • Sholar M.
        • Yang J.
        • et al.
        Elevated serum cardiac markers in asymptomatic marathon runners after competition: is the myocardium stunned.
        Cardiology. 1997; 88: 487-491
        • Saenz A.J.
        • Lee-Lwandrowski E.
        • Wood M.J.
        • et al.
        Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon.
        AJCP. 2006; 126: 185-189
        • Young A.
        Plasma creatine kinase after the marathon – a diagnostic dilemma.
        Br J Sports Med. 1984; 18: 269-272
        • Legaz-Arrese A.
        • George K.
        • Carranza-Garcia L.E.
        • et al.
        The impact of exercise intensity on the release of cardiac biomarkers in marathon runners.
        Eur J Appl Physiol. 2011; 111: 2961-2967
        • Koller A.
        Exercise-induced increases in cardiac troponins and prothrombotic markers.
        Med Sci Sport Exerc. 2003; 35: 444-448
        • Whyte G.
        • George K.
        • Shave R.
        • et al.
        Impact of marathon running on cardiac structure and function in recreational runners.
        Clin Sci. 2005; 108: 73-80
        • Urhausen A.
        • Scharhag J.
        • Herrmann M.
        • et al.
        Clinical significance of increased cardiac troponins T and I in participants of ultra-endurance events.
        Am J Cardiol. 2004; 94: 696-698